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Jaagsiekte sheep retrovirus (JSRV) is the causative agent of ovine pulmonary adenocarcinoma (OPA), a sheep lung cancer
that resembles human lung adenocarcinoma or bronchioloaveolar carcinoma (BAC). JSRV is the only retrovirus that shows
lung tropism and induces pulmonary carcinoma. Several lines of evidence suggest that the lung tropism for JSRV is mainly
determined by the viral long terminal repeats (LTR). In a previous study, we showed that HNF-3a and -3b were able to
transactivate the JSRV LTR when cotransfected into 3T3 cells. The JSRV LTR contains two putative HNF-3 binding sites; to
investigate the contribution of each HNF-3 binding site to transcription, we generated reporter constructs with deletions or
nucleotide substitutions in one or both of the putative HNF-3 binding sites. In murine MLE-15 cells (derived from type II
pneumocytes), mutations within the upstream site (2147 to 2128 bp) resulted in a 72% reduction of the LTR activity, while
mutation of the downstream site had little effect. In contrast, transactivation of the JSRV LTR was greatly reduced in 3T3 cells
cotransfected with an HNF-3a or -3b expression plasmid when the downstream site was eliminated. Electrophoretic mobility
shift assays (EMSA) revealed that nuclear extracts from MLE-15 cells, but not 3T3 cells, were able to form a retarded
complex with oligonucleotides encompassing either the upstream or the downstream sites. Anti-HNF-3b antiserum, but not
anti-HNF-3a antiserum, supershifted both protein–DNA complexes. These results indicate that the JSRV LTR is activated by
the lung-specific transcription factor HNF-3b and that the upstream HNF-3 binding site is essential for expression in MLE-15
cells. In contrast, transactivation by HNF-3b in 3T3 cells is mediated through the downstream HNF-3 site. On the other hand,
JSRV LTR expression in a mouse lung Clara cell-derived line (mtCC1–2) did not appear to be strongly dependent on either
HNF-3 binding site. These results support the notion that JSRV lung tropism is determined by the transcriptional specificity
of the JSRV LTR, which is governed by interactions with lung-specific transcription factors. © 2002 Elsevier ScienceINTRODUCTION
Jaagsiekte sheep retrovirus (JSRV) is the causative
agent of ovine pulmonary adenocarcinoma (OPA) (Bai et
al., 1996; DeMartini and York, 1997; Palmarini et al.,
1996a, 1997, 1999a; York, 1992), a naturally occurring lung
cancer of sheep that closely resembles human adeno-
carcinoma of the deep airways, including bronchi-
oloaveolar carcinoma (BAC) (Perk and Hod, 1982). Lung
cancer is the primary cause of deaths among cancer
patients (Landis et al., 1999) and animal models are
necessary to study its causes and mechanisms of cell
transformation. The incidence of human lung adenocar-
cinoma has steadily risen and now is responsible for up
to one-quarter of lung cancer fatalities (Barsky et al.,
1994; Landis et al., 1999). Thus OPA presents a unique
opportunity to study the mechanisms of lung carcinogen-
esis.
Retroviruses have historically given insights into the
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87mechanisms of oncogenesis. However, most retrovi-
ruses induce transformation of hematopoietic cells,
whereas the great majority of human cancers originate
from epithelial tissues. JSRV induces transformation of
the differentiated epithelial cells of the lungs: type II
pneumocytes (Mason and Shannon, 1997; Voelker and
Mason, 1989) and Clara cells (Plopper et al., 1997). Both
in vivo and in vitro, JSRV infects several different cell
types (Holland et al., 1999; Palmarini et al., 1996b, 1999b).
However high-level viral expression occurs only in the
differentiated epithelial cells of the lungs (Palmarini et al.,
1995, 2000a). We have recently reported that the tropism
for the differentiated epithelial cells of the lungs is cor-
related with the transcriptional specificity of the viral
long-terminal repeats (LTRs) for these cells (Palmarini et
al., 2000a). The retroviral LTRs contain the viral promoter
and enhancer elements.
The JSRV LTR contains two putative binding sites for
HNF-3, a transcription factor of the hepatocyte nuclear
factor-3/forkhead homology protein family (Overdier et
al., 1994; Palmarini et al., 2000a). This subset of nuclear
proteins is widely expressed in hepatic and lung tissues
and plays a pivotal role in development (Costa et al.,
2001; Kaufmann and Knochel, 1996). HNF-3a and -3b
isoforms are highly expressed in both type II pneumo-
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88 MCGEE-ESTRADA, PALMARINI, AND FANcytes and Clara cells (Clevidence et al., 1994; Kaestner et
al., 1994) and they regulate the transcription of several
lung-specific genes, including surfactant protein B (SP-B)
(Bohinski et al., 1994; Bruno et al., 1995; Clevidence et al.,
1994; Costa et al., 2001; Margana and Boggaram, 1996,
1997; Whitsett and Glasser, 1998) and CC10 (Bingle and
Gitlin, 1993; Bingle et al., 1995; Costa et al., 2001; Sawaya
et al., 1993). Studies into the lung tropism of this virus
have been hampered by the lack of a sheep cell line
derived from the differentiated epithelial cells of the
lungs. However, the use of a mouse cell line (MLE-15)
derived from type II pneumocytes (Wikenheiser et al.,
1993) has allowed demonstration of the preferential ex-
pression of the JSRV LTR in these cells (Palmarini et al.,
2000b). In addition, we were able to demonstrate that
FIG. 1. pJS21luc mutants. (A) The JSRV LTR was previously scanned fo
et al., 2000). Positions of the two putative HNF-3 binding sites are show
canonical HNF-3 binding sites were deleted (crossbars) or mutated (CHNF-3a and HNF-3b were capable of transactivating the
JSRV LTR when expressed in NIH-3T3 cells (that nor-mally do not support high-level expression of the JSRV
LTR) (Palmarini et al., 2000b). In this study, we have
further investigated the role of HNF-3 in transcriptional
activation of the JSRV LTR.
RESULTS
Transcription from the JSRV LTR in a type II
pneumocyte line is dependent on the upstream
HNF-3 site
The JSRV LTR contains two putative HNF-3 binding
sites: “upstream” (2147 to 2128) and “downstream” (248
to 229). The upstream site is in a position within the
enhancer region, while the downstream site is close to
the basal promoter (Fig. 1A) (Palmarini et al., 2000b). To
tial transcription factor binding site (Palmarini et al., 2000b; Wingender
SRV LTR reporter plasmids used in this study are shown. One or both
).r potenevaluate the importance of each HNF-3 site to JSRV LTR
activity, we prepared a series of luciferase reporter plas-
tes we
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our previous pJS21luc plasmid (Palmarini et al., 2000b).
One series of mutants contained six-base deletions of
the core sequences within the upstream or downstream
HNF-3 binding sites (Fig. 1B; designated by the term “D”).
To ensure that changes in transcriptional activity were
not due to distance or spatial effects caused by nucleo-
tide removal, we also generated mutants that changed
the core sequences from TPuTTTPu to CCCCCC (desig-
nated by the term “m”).
We tested the activity of the mutant LTRs in transient
FIG. 2. Activity of mutant LTRs. The mutant pJS21luc reporter construc
of each mutant were determined after 48 h and are shown relative to
pRLnull plasmid to correct for transfection efficiency. At least 12 replica
is indicated by the error bar.transfection of MLE-15 cells. These cells were derived
from a tumor of type II pneumocytes that arose in atransgenic mouse expressing the SV40 large T antigen
under control of the pulmonary surfactant protein C pro-
moter (Wikenheiser et al., 1993). MLE-15 cells display a
number of differentiation properties associated with type
II pneumocytes, including synthesis of lung-specific pro-
teins and expression of the transcription factors HNF-3a
and HNF-3b (Wikenheiser et al., 1993). The activity of the
mutant LTRs in MLE-15 cells is shown in Fig. 2A. Dele-
tion or mutation of the upstream HNF-3 site resulted in
substantial (four- to fivefold) reduction in LTR activity. In
contrast, mutation or deletion of the downstream HNF-3
transfected into MLE-15 (A) or NIH-3T3 (B) cells. Luciferase activities
-type LTR. Each assay included cotransfection with the promoterless
re tested for each mutant plasmid and the standard error of the meants were
the wildsite had little effect on LTR activity. These results indi-
cated that the upstream, but not the downstream, HNF-3
90 MCGEE-ESTRADA, PALMARINI, AND FANsite in the JSRV LTR is important for optimal expression
in MLE-15 cells.
We also tested these LTRs in NIH3T3 cells (murine
fibroblasts). We previously showed that NIH3T3 cells
support only low-level transcription from the JSRV LTR
(Palmarini et al., 2000a), and these cells do not express
either HNF-3 isoform. Deletion or mutation of either the
upstream or downstream HNF-3 site had little effect
(,twofold reduction) on LTR activity, consistent with the
fact that these cells do not express either HNF-3 isoform
(Fig. 2B). (The data in Fig. 2 were normalized to the
activity of the wild-type JSRV LTR in the same cell type;
we have previously shown that the JSRV LTR has sub-
stantially higher activity in MLE-15 than in NIH3T3 cells
(Palmarini et al., 2000a).)
We previously showed that coexpression of either
HNF-3a or HNF-3b in NIH3T3 cells along with pJS21luc
resulted in a dose-dependent increase in LTR activity
(Palmarini et al., 2000a). To test if the inductive effect of
HNF-3b involved the upstream or downstream HNF-3
sites in the JSRV LTR, NIH3T3 cells were cotransfected
with the different LTR-reporter plasmids and increasing
amounts of an HNF-3b expression plasmid, as shown in
Fig. 3. In contrast to the results obtained in MLE-15 cells,
mutation or deletion of the upstream HNF-3 site had no
effect on the ability of HNF-3b to activate transcription of
the JSRV LTR. In contrast, mutation or deletion of the
downstream HNF-3 site abolished HNF-3b inducibility.
Similar results were obtained with an expression plas-
mid for HNF-3a (not shown). Thus, unlike in MLE-15 cells
where the upstream HNF-3b site is critical for JSRV LTR
expression, this site was not important for LTR expres-
sion in NIH3T3 cells, even when they expressed HNF-3b.
Conversely, the downstream HNF-3 site was not impor-
tant for LTR expression in MLE-15 cells, but it was critical
for expression in NIH3T3 cells when they express
HNF-3b or -3a.
HNF-3b binds to the upstream HNF-3 site
in MLE-15 cells
Since MLE-15 cells express both HNF-3a and HNF-3b
(Wikenheiser et al., 1993), we wished to determine which
isoform was binding to the JSRV LTR. Therefore we
performed a series of electrophoretic mobility shift as-
says (EMSAs). Nuclear extracts were prepared from
MLE-15 and NIH3T3 cells and incubated with radioactive
double-stranded oligonucleotide probes containing se-
quences encompassing the core binding regions and
surrounding bases from either the upstream or down-
stream HNF-3 sites. After incubation, the extracts were
analyzed by nondenaturing polyacrylamide gel electro-
phoresis and autoradiography (Fig. 4A). As expected
from the lack of HNF-3 expression in NIH3T3 cells, the
EMSAs with these cell extracts revealed no retarded
complexes with either probe. On the other hand, theMLE-15 cell extracts formed complexes with both the
upstream and the downstream probes. The upstream
probe consistently formed complexes more efficiently
than the downstream probe, and all complexes were
eliminated by the addition of 100-fold excess of unla-
beled homologous competitor. The upstream probe
showed formation of one complex, while the down-
stream probe showed formation of two complexes—one
with a similar mobility to the complex formed by the
upstream probe and an additional more slowly migrating
complex. To test if any of the complexes contained
HNF-3 isoforms, rabbit antisera raised against mouse
HNF-3a or HNF-3b were added to the mixtures prior to
FIG. 3. Activity of mutant LTRs in 3T3 cells expressing HNF-3b. 3T3
cells were cotransfected with pCMV-HNF-3b (1–200 ng) and constant
amounts (200 ng) of the JSRV deletion (A) or substitution (B) mutant
reporter plasmids. Each assay included cotransfection with the pro-
moterless pRLnull plasmid to correct for transfection efficiency. At least
12 replicates were tested for each mutant plasmid.incubation and electrophoresis. Retarded (supershifted)
complexes were observed when the antibody to HNF-3b
.1 vec
n.
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the case of the downstream probe, addition of anti-
HNF-3b diminished the intensity of the more rapidly
migrating complex, but not of the more slowly migrating
FIG. 4. Detection of cellular factors binding to the JSRV HNF-3 conse
were incubated with 32P-labeled oligonucleotides encompassing the u
bated with rabbit anti-mouse HNF-3a (lanes 2, 7, 12, and 17), HNF-3b (la
with excess unlabeled homologous oligonucleotide (lanes 5, 10, 15,
prepared from 3T3 cells transiently expressing HNF-3b were incubated
nuclear extracts from 3T3 cells transfected with the empty pcDNA3
electrophoretic mobility shift analysis (EMSA) was carried out as showone. These results indicated that HNF-3b, but not HNF-
3a, binds to both the upstream and the downstreamHNF-3 sites in the JSRV LTR in MLE-15 cells. Moreover,
only the more rapidly migrating complex formed with the
downstream probe appeared to contain either HNF-3b or
HNF-3a.
ements. (A) Nuclear extracts from NIH-3T3 (left) or MLE-15 (right) cells
or downstream HNF-3 binding sites. Some reactions were preincu-
8, 13, and 18), or preimmune (lanes 4, 9, 14, and 19) serum. Competition
0) confirmed specific protein–DNA interactions. (B) Nuclear extracts
upstream or downstream radiolabeled probe. Binding reactions using
tor were included as a control. Non-denaturing polyacrylamide gelnsus el
pstream
nes 3,
and 2
with theIn light of the fact that coexpression of HNF-3b in
NIH3T3 cells could lead to activation of the JSRV LTR, we
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NIH3T3 cells that had been transiently transfected with
the HNF-3b expression plasmid (Fig. 4B). A weak but
detectable shifted complex was detected with the down-
stream probe, while the upstream probe more efficiently
formed complexes—the same as in MLE-15 cells. This
result was somewhat unexpected, since, as shown in
Fig. 4B, the downstream HNF-3 site was essential for
HNF-3b induction of the JSRV LTR in NIH3T3 cells, while
the upstream site was dispensable. Thus, it had seemed
possible that in these cells, the binding of HNF-3b to the
downstream sequence might show higher affinity. How-
ever, this was not the case.
HNF-3b binds to the upstream HNF-3 site with higher
affinity than to the downstream site
Previous reports have shown that different HNF-3
binding sites have different affinities for the factors (Bo-
hinski et al., 1994; Overdier et al., 1994). The nucleotides
surrounding the core sequence often dictate how effi-
ciently a site will bind HNF-3 and activate transcription
(Overdier et al., 1994). In competition assays, a 100-fold
excess of an unlabeled oligonucleotide of weaker affinity
will not completely compete HNF-3 binding to a radioac-
tive high-affinity sequence (Bohinski et al., 1994). The
experiments in Fig. 4 suggested that the upstream HNF-3
site in the JSRV LTR might have a higher affinity of
binding for HNF-3b in the downstream site. To test this
formally, we compared the relative affinities of the two
sites by competition binding experiments, as shown in
Fig. 5A. Unlabeled downstream oligonucleotide com-
peted formation of the labeled upstream complex less
efficiently than unlabeled upstream oligonucleotide
(lanes 2 and 3, left panel). As expected, unlabeled up-
stream or downstream oligonucleotides that had muta-
tions in the core HNF-3 sequence showed no competi-
tion. Likewise, a commercially available competitor oli-
gonucleotide containing a canonical HNF-3 binding
sequence showed efficient competition (Overdier et al.,
1994). When competition for binding to the downstream
HNF-3 sequence was studied (right panel), the unlabeled
upstream oligonucleotide showed efficient competition
of the more rapidly migrating complex, equal to compe-
tition by the unlabeled downstream oligonucleotide
(lanes 2 and 3). It was interesting that the more slowly
migrating complex was not competed by the upstream
oligonucleotide, but (as expected) it was competed by
the downstream oligonucleotide. Taken together with the
results of Fig. 4A, in which antibody to HNF-3b did not
supershift the more slowly migrating complex, these re-
sults suggest that HNF-3b binds with higher affinity to
the upstream site in the JSRV LTR, and that the down-
stream site can additionally form a complex with some
other protein(s) that does not contain HNF-3b. Consis-
tent with this, the commercial competitor oligonucleotidecontaining the canonical HNF-3 binding sequence effi-
ciently competed the more rapidly migrating complex
formed by the downstream oligonucleotide, while it had
no effect on the more slowly migrating complex.
As another test of the binding affinities for the up-
stream and downstream HNF-3 sites, different amounts
of MLE-15 cells nuclear extracts were incubated with
constant amounts of the upstream or downstream
probes, followed by EMSA assay (Fig. 5B). As shown, the
upstream probe formed complexes more efficiently with
the same amount of nuclear extracts than did the down-
stream probe. This was consistent with more efficient
binding on the upstream HNF-3 site to HNF-3b.
The HNF-3 binding sites in the JSRV LTR are not
important for transcriptional activity in a Clara
cell line
We also made use of a mouse Clara cell line,
mtCC1–2, which previously displayed a relatively high
level of LTR activity (albeit fourfold lower compared to
MLE-15 cells (Palmarini et al., 2000b)). This cell line was
established from the lungs of transgenic mice express-
ing the SV40 large T antigen driven by the Clara cell-
specific CC10 promoter, and it maintains a differentiated
phenotype, including expression of the Clara cell protein
CC10 and HNF-3 isoforms a and b (Magdaleno et al.,
1997). As shown in Fig. 6, alteration of either HNF-3 site
had little or no effect (, twofold) on LTR activity in the
mouse Clara cell line mtCC1–2, although these cells
express HNF-3 (Magdaleno et al., 1997). These results
indicated that HNF-3(a or b) does not play a large role in
JSRV expression in Clara cells.
DISCUSSION
In this report we studied the role of the HNF-3 tran-
scription factor in activity of the JSRV LTR. We focused on
HNF-3 for two reasons: first, HNF-3a and -3b are key
transcription factors in lung tissue (Costa et al., 2001);
and second, we previously showed that vectored expres-
sion of HNF-3a or -3b in NIH3T3 cells (that do not
support high activity of the JSRV LTR) led to increased
JSRV LTR activity (Palmarini et al., 2000b). The two HNF-3
sites in the JSRV LTR were systematically deleted or
mutated, and the effects on transcriptional activity in a
type II pneumocyte-derived cell line (MLE-15) or in a
Clara cell line (mtCC1–2), and in NIH3T3 cells express-
ing HNF-3b, were studied.
The studies in MLE-15 cells indicated that HNF-3b is
essential for high transcriptional activity of the JSRV LTR.
In particular, deletion or mutation of the upstream HNF-3
site resulted in substantial loss of LTR activity. On the
other hand, mutation of the downstream HNF-3 site did
not substantially reduce LTR activity, indicating that the
downstream site is not essential for expression in these
cells. EMSA assays and supershifts indicated that
nstream
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FIG. 5. Relative binding affinities of HNF-3b to the upstream and dow
(left) or downstream (right) 32P-labeled probe and an unlabeled homolo
carried out. (B) The labeled probes were incubated with (from right towithin the JSRV LTR. Thus, in MLE-15 cells, the critical
interaction appears to be binding of HNF-3b to the up-stream HNF-3 site. The fact that the upstream but not the
sites. (A) MLE-15 nuclear extracts were incubated with the upstream
r heterologous competitor oligonucleotide. EMSA analyses were then
0.625, 1.25, 2.5, and 5 mg MLE-15 nuclear extracts.downstream HNF-3 site is essential for JSRV LTR activity
in MLE-15 cells was not surprising. The binding affinity of
eporte
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to the downstream core sequence (Fig. 5).
In viral and cellular promoter/enhancers, interactions
between enhancer binding factors (or between enhancer
binding proteins and basal transcription factors) are im-
portant in determining overall transcriptional activity and
specificity. HNF-3 has been found to cooperate with
other lung-specific and ubiquitous transcription factors,
including thyroid transcription factor-1 (TTF-1) and NF-1
(Arenzana and Rodriguez de Cordoba, 1996; Bohinski et
al., 1994; He et al., 2000; Nord et al., 2000; Tsay et al.,
1996, 1997). It is noteworthy that in the JSRV LTR, the
upstream HNF-3 site is immediately adjacent to an NF-1
site (Fig. 1A). On the other hand, the downstream HNF-3
site is not adjacent to an NF-1 site; however, it is flanked
by Oct-1 sites. It seems possible that in MLE-15 cells
simultaneous binding of HNF-3 and NF-1 to the upstream
HNF-3 site leads to efficient activation of transcription.
Future experiments will explore this possibility.
It should be noted that the experiments in MLE-15
cells, while demonstrating that HNF-3b is essential for
high JSRV LTR activity, do not imply that this factor is the
only important one. In addition to the potential role of
NF-1, we have also previously shown that deletion or
mutation of an upstream NF-kB site results in loss of
approximately one-half of the LTR activity (Palmarini et
al., 2000b). Thus binding of an NF-kB-like factor to this
sequence is also important for transcription in MLE-15
cells. However, in our previous studies, the factor bind-
ing to the upstream NF-kB site did not appear to be
genuine NF-kB (Palmarini et al., 2000b); rather some
other factor that binds to the NF-kB site was involved.
Clara cells also support a high level of JSRV LTR
activity, but the results indicated that HNF-3 is not es-
FIG. 6. Activity of mutant LTRs in Clara cells. The mutant pJS21luc r
Fig. 2.sential for JSRV expression in Clara cells. Mutation of
either HNF-3 binding site did not have significant effectson LTR activity in the mouse Clara cell line mtCC1–2,
even though these cells express HNF-3 (Magdaleno et
al., 1997). One possible explanation of this discrepancy
is that mtCC1–2 cells may contain a different array of
transcription factors such that HNF-3 binding to the LTR
is blocked by binding and steric hindrance by a neigh-
boring transcription factor. Alternatively, HNF-3 may bind
to the JSRV LTR in Clara cells, but simultaneous binding
of another factor necessary for cooperative stimulation of
the LTR may not occur. At the very least, these results
indicate that the JSRV LTR utilizes different combinations
of transcription factors in type II pneumocytes vs Clara
cells. It has been observed that the mouse mammary tumor
virus LTR, which is active in both lymphoid cells and mam-
mary epithelial cells, employs different transcription factors
in these two cell types (reviewed in Beato, 1996).
The studies in NIH3T3 cells led to some surprising
findings. As expected, the EMSA assays showed no
formation of complexes when either the upstream or
downstream HNF-3 core oligonucleotides were incu-
bated with NIH3T3 cell extracts, since these cells do not
normally express HNF-3a or -3b. When HNF-3b was
coexpressed along with the JSRV LTR reporter plasmid in
NIH3T3 cells, this resulted in stimulation of transcrip-
tional activity. This was consistent with the importance of
HNF-3b for high JSRV LTR activity, as in MLE-15 cells.
However, analysis with the mutant JSRV LTRs indicated
that in the NIH3T3 cells, the upstream HNF-3 site was
dispensable for HNF-3b induction, while the downstream
site was essential. This was exactly opposite from the
situation in MLE-15 cells. This was not due to a different
affinity between HNF-3b and the upstream vs down-
stream core oligonucleotides in transfected NIH3T3 vs
MLE-15 cells (Fig. 4).
r constructs were transfected into mtCC1–2 cells and analyzed as inOne explanation for the different behaviors of the mu-
tant LTRs in MLE-15 vs HNF-3b-expressing NIH3T3 cells
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different set of nuclear factors that can bind to other
sequence motifs in the JSRV LTR. For instance, if coop-
erative binding of HNF-3b and NF-1 is essential for
activation from the upstream HNF-3 site, it is possible
that MLE-15 cells express isoforms of NF-1 (e.g., splice
variants or appropriately phosphorylated forms (Kruse
and Sippel, 1994a,b; Rupp et al., 1990)) that can bind to
the adjacent NF-1 site and cooperate with HNF-3b.
These NF-1 isoforms might not be expressed in
NIH3T3—although NIH3T3 cells do express some forms
of NF-1 (Granger and Fan, 1998). Conversely, it is possi-
ble that Oct-1 isoforms in NIH3T3 cells can bind to the
site(s) flanking the downstream HNF-3 site, while this
might not be the case in MLE-15 cells. It will be interest-
ing to test these possibilities in the future.
Finally, it should be noted that while MLE-15 cells
possess many properties associated with normal type II
pneumocytes, there might also be differences. Ulti-
mately, it would be interesting to determine the impor-
tance of HNF-3 for expression of the JSRV LTR in primary
type II pneumocytes (preferably ovine). In addition, anal-
ysis in primary Clara cells will be important.
MATERIALS AND METHODS
Cell cultures
MLE-15 cells (provided by J. Whitsett, Cincinnati, OH)
were grown in RPMI 1640 (Gibco BRL), 2% FBS, 0.5% ITS
(Sigma), modified with the addition of 5 mg/L transferrin,
10 mM HEPES, 1 3 1028 M b-estradiol and 1 3 1028 M
hydrocortisone. 3T3 (ATCC) and mtCC1–2 cells (provided
by Dr. F. DeMayo, Baylor College of Medicine, Houston,
TX) were grown in DMEM (ATCC) and 10% FBS. All three
cell types were cultured at 37°C with 5% CO2.
Oligonucleotides
For the electrophoretic mobility shift assays, the follow-
ing double-stranded oligonucleotide probes were used:
EMSAHNF3up (GCTCGGATGTTTGCTTTTGG) and EMSA-
HNF3down (TAATGAATAAACAAGTTATG). For competition
EMSAs, the following double-stranded mutant oligonucle-
otides were used: EMSADHNF3up (GCTCGGACCCCCC-
CTTTTGG) and EMSADHNF3down (TAATGAACCCCCCA-
GTTATG); mutated nucleotides are shown in bold.
EMSAHNF3up and EMSAHNF3down correspond to posi-
tions 2147 to 2128 and 248 to 229 of the U3 of JSRV21,
respectively, and both include an HNF-3 binding site (un-
derlined). EMSADHNF3up and EMSADHNFdown have six
nucleotide substitutions that completely eliminate the
HNF-3 putative binding site. An oligonucleotide probe en-
compassing the HNF-3 consensus binding sequence and a
mutant oligonucleotide were purchased from Geneka as a
positive control.Plasmids
pJS21luc was constructed by cloning the JSRV21 LTR
directly upstream of the firefly luciferase gene in
pGL3basic, as previously described (Palmarini et al.,
2000a). PCRs were performed using the PfuTurbo poly-
merase (Stratagene) as recommended by the manufac-
turers.
Deletions and alterations of the HNF-3 sites were
generated by PCR mutagenesis. Schematic diagrams of
each mutant are depicted in Fig. 1.
For the transactivation experiments, we used the fol-
lowing expression plasmids. Plasmids pCMV-HNF-3a
and pCMV-HNF-3b expressing the hepatocyte nuclear
factors 3a and b were originally developed by R. H.
Costa (University of Illinois) and provided by G. Suske.
The plasmid pRLnull (Promega), a promoterless plasmid
with the Renilla luciferase gene, was used to adjust the
luciferase values for transfection efficiency and lysates
preparation.
All constructs were verified by nucleotide sequencing
and/or restriction digestion.
Transient transfection and luciferase assays
Transient transfections were performed on 2–4 3 105
cells plated on six-well plates (Falcon) approximately
24 h before transfection. For each well, 250–300 ng of
plasmid DNA (200 ng of reporter plasmid and 50 or 100
ng pRLnull to adjust for transfection efficiency in MLE-15
or 3T3 cells, respectively) and 6 ml fugene (Boehringer)
were used as recommended by the manufacturers. Ex-
periments were performed using the dual luciferase re-
porter system (Promega). Activity of the mutant reporter
plasmids was calculated as the percentage activity rel-
ative to the wild-type reporter construct.
For the transactivation experiments, 200 ng of reporter
plasmid, 1–200 ng of the transactivating plasmid (or a
control plasmid containing the same promoter as the
transactivating plasmid), and 100 ng pRLnull were trans-
fected into 3T3 cells. Fold activation was calculated by
comparing the relative activity of the reporter construct
cotransfected with either pCMV-HNF-3a/b or the empty
pcDNA3.1 vector.
After 48 h, transfected cells were washed with PBS
and lysed with 500 ml/well of passive lysis buffer (Pro-
mega). Dual luciferase assays were performed on 20 ml
of cleared lysate by rapid addition of luciferase assay
reagent (Promega) and light output was integrated over
10 s at room temperature using a Moonlight 2010 lumi-
nometer (Analytical Luminescence Laboratory). Lucif-
erase activity was normalized for transfection efficiency
and cell extract preparation by sequentially measuring
Renilla luciferase activity.
All of the experiments above were performed in at
least 12 independent transfections using two separate
DNA preparations. Results were expressed as mean 6
96 MCGEE-ESTRADA, PALMARINI, AND FANstandard error (95% confidence interval). The linear
range of the reaction was predetermined.
3T3 nuclear extracts were prepared from cells tran-
siently transfected with pCMV-HNF3b or pcDNA3.1. Cells
were grown to 80% confluency before transfection. For
each 10-cm plate, 1.4 mg DNA and 42 ml fugene were
used as recommended by the manufacturers. Nuclei
were harvested 48 h after transfection.
Nuclear extracts, electrophoretic mobility shift assays
(EMSA)
Nuclear extracts were prepared from MLE-15 cell lines
as described previously (Dignam et al., 1983; Palmarini et
al., 2000b). 3T3 cell line nuclear extracts was purchased
from Geneka. Nuclear extracts from 3T3 cells transiently
expressing HNF-3b were prepared using a miniextract
procedure, as described previously (Bachurski et al.,
1997; Bohinski et al., 1993). Protein concentrations were
determined by Bradford assay (Bio-Rad).
Oligonucleotide probes were labeled with [g-32P]ATP
using T4 polynucleotide kinase. All binding reactions
were performed at room temperature using buffers pur-
chased from Geneka and under conditions recom-
mended by the manufacturer. Nuclear extracts were in-
cubated with the probe for 30 min before electrophore-
sis. Rabbit antisera raised against mouse HNF-3a or
HNF-3b were kindly provided by Robert Costa. For su-
pershift assays, 1 ml preimmune, a-HNF-3a, or a-HNF-3b
antiserum was preincubated with nuclear extracts for 30
min. In competition gel shifts, the probe and cold com-
petitor oligonucleotide were premixed prior to incubation
with nuclear extracts. Each binding reaction was sub-
jected to electrophoresis through a 5% non-denaturing
polyacrylamide gel in 13 TGE buffer. After 2 h, gels were
dried and exposed to film at 270°C for approximately
5 h.
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